1,2-Dihydroparatocarpin A的全合成

以对羟基苯甲醛和2,4-二羟基苯乙酮为起始原料,经C-异戊烯基化、保护酚羟基、羟醛缩合、DDQ环化及对甲基苯磺酸催化环化等反应,首次完成了天然异戊烯基查尔酮衍生物1,2-Dihydroparatocarpin A的全合成,总收率21.8%。化合物的结构经1H NMR,IR和MS确认。     

五个天然异戊烯基黄酮的首次全合成研究

完成了具有2,3-二羟基-3-甲基丁基黄酮化合物brosimacutin A-B,brosimacutin D,brosimacutin E,brosimacutin H和brosimacutin M五个黄酮类化合物的消旋体的合成.所有新化合物的结构都经过NMR,HRMS确认.     

两种天然异戊烯基黄烷酮的全合成

以3-甲氧基甲氧基苯甲醛和2,4,6-三甲氧基-3-异戊烯基苯乙酮为原料,经烷基化和缩合反应合成了新化合物——2’-羟基-4-甲氧基-3,4’,6’-三甲氧甲氧基-3’-异戊烯基査尓酮(6);6经环合反应合成了新化合物——(±)-5,7,3’-三甲氧甲氧基-4’-甲氧基-8-异戊烯基黄烷酮(7);7经脱保护和环合反应实现了天然产物(±)-5,7,3’-三羟基-4’-甲氧基-8-异戊烯基-黄烷酮(1,总收率11.6%)和(±)-5,3’-二羟基-7,8-(2,2-二甲基吡喃)-4’-甲氧基黄烷酮(2,总收率10.5%)的全合成,其中1为新化合物,其结构经1H NMR,IR和MS表征。     

异戊烯基查尔酮的合成与抗肿瘤活性

以2,4,6-三羟基苯乙酮为原料,依次经亲核取代、重排、羟醛缩合、水解等反应,合成了15个异戊烯基查尔酮类化合物（6a~6i和9a~9f）,其结构经¹H NMR,¹³C NMR和ESI-MS等表征。用MTT法评价了目标化合物对乳腺癌细胞（MDA-231）、前列腺癌细胞（LNCAP）、人肺癌细胞（A549）、肾癌细胞（A498）和宫颈癌细胞（Hela）增殖的抑制活性。结果表明：化合物6h、 6i和9a对肾癌细胞（A498）具有一定的抑制活性,在5 µmol/L浓度下抑制率分别达到了59.12%、 49.82%和50.95%;化合物6h和6i对宫颈癌细胞（Hela）的抑制率可达59.19%和41.87%;化合物6h和6i对人肺癌细胞（A549）抑制率可达62.65%和54.82%。      

5′位羟基异戊烯基查尔酮类天然产物的合成及其抗菌活性研究

首次合成了Bartericin A (1), 2’,6’-二羟基-5’-(2’’-羟基-3’’-甲基-3’’-丁烯基)-4’-甲氧基查尔酮(2), Xanthohumol D (3)和Angusticornin B (4) 4个羟基异戊烯基查尔酮类天然产物.为了探讨天然产物中不同官能团对其核心骨架结构抗菌活性的影响,设计合成了衍生物6.所合成的目标产物和未知中间体化合物经过1H NMR、13C NMR、IR、HRMS进行了确证.选取大肠杆菌[CMCC(B)44102]、绿脓杆菌[CMCC(B)10104]、金黄色葡萄球菌[CMCC(B)260003]和枯草芽孢杆菌[CMCC(B)63 501],采用稀释点样法对所合成的4个天然产物及1个新型衍生物进行了抗菌活性评估.结果显示,天然产物1、4和衍生物6对革兰氏阳性菌金黄色葡萄球菌和枯草芽孢杆菌表现出了一定的抑制活性.天然产物3对枯草芽孢杆菌表现出了较为明显的抑制活性,但对其他3种菌株无抑制活性(最小抑菌浓度>200μg/mL).     

(±)-Cycloaltilisin 7和(±)-Poinsettifolin B的首次全合成

Cycloaltilisin 7是从桑科植物面包树(Artocarpus altilis)的芽中分离出的一种新异戊烯基黄烷酮,具有组织蛋白酶K抑制活性;Poinsettifolin B也是从桑科琉桑属植物Dorstenia poinsettifolia中分离出的一种新的香叶基查尔酮,Dorstenia poinsettifolia是原产于喀麦隆潮湿森林的草本植物,用于民间雅司病和伤口感染的治疗,对治疗皮肤病也有潜在功效.以廉价的羟苯乙酮和羟苯甲醛为原料,用简单温和的方法完成了这两种天然产物的首次全合成.所有新化合物的结构都经过HRMS,1H NMR和13C NMR的确认.     

Coryfolia D的全合成

以3,4-二羟基苯甲醛和2,4-二羟基苯乙酮为起始原料,经C-异戊烯基化、保护酚羟基、羟醛缩合、催化环化、DDQ脱氢及去保护基等反应,首次完成了天然产物异戊烯基黄酮Coryfolia D的全合成,总收率11.8％.所有新化合物的结构经1H NMR,IR和MS表征.     

异戊烯基取代的黄烷酮衍生物的合成及杀菌活性

异戊烯基溴;异戊烯基取代的黄烷酮衍生物的合成及杀菌活性     

Total Synthesis of Terpioside B

The first total synthesis of terpioside B ( 1 ) has been accomplished. Key steps include the stereoselective installments of a set of challenging 1,2-cis-glycosidic linkages. Thus, α(1,4)-linked d -galactoside was effectively constructed from a 1,2-anhydrogalactose donor and an unprotected 1,6-anhydrogalactose acceptor by using a boron-mediated aglycon delivery (BMAD) method. In addition, α-l -fucofuranosides were stereoselectively and simultaneously constructed by remote group-assisted 1,2-cis-α-stereoselective glycosylations.     

Total Synthesis of Cytosporone B

The total synthesis of Cytosporone B, a naturally occurring agonist for Nur77, has been accomplished. The key steps are the sequential Grignard reaction and Lemieux‐van Rudloff oxidation followed by a deprotection of the methyl aromatic ether to phenol and subsequent Friedel‐Crafts acylation.     

Total Synthesis of Secobatzelline B

A concise and efficient total synthesis of Secobatzelline B is reported. The synthesis involves eight steps starting from known 4,6,7‐trimethoxyindole. Synthetic tactics involve a one‐step reduction of an indole‐3‐glyoxalic ester using LiAlH₄, resulting in complete reduction of the ester group and a partial reduction of the vinylogous amide carbonyl group. Synthesis also involves the use of a mixture of NaCl and oxone as a new reagent for regioselective chlorination of an indoloquinone derivative.     

Total Synthesis of Principinol B

We have accomplished the first and asymmetric total synthesis of principinol B, a grayanoid possessing an oxabicyclo[3.2.1] architecture. A functionalized 5/7/6/5 tetracyclic intermediate was assembled in a convergent manner by a diastereoselective intermolecular aldol reaction and subsequent carbonyl–olefin metathesis of two enantiomerically enriched fragments. The oxabicyclo[3.2.1] architecture containing a 6,10-ether bridge was constructed by the Williamson ether synthesis.     

Total Synthesis of (+)-Saponaceolide B

Coupling of three fragments results in the first total synthesis of a saponaceolide (see scheme). The first fragment, the spiroketal portion, is formed from two moieties, one derived from geraniol and the other from allyl malonate. A sulfone alkylation-desulfonylation sequence joins the spiroketal portion to the methylene-3,3-dimethylcyclohexane unit. The subsequent stereoselective Wittig reaction attaches the final piece to complete the synthesis of saponaceolide B (1), one of the most biologically active members of this family.     

Concise Total Synthesis of Ivorenolide B

An expeditious route to the potential immunosuppressive lead compound ivorenolide B ( 1 ) is described, which relies on the formation of the distinctive 1,3‐diyne subunit embedded into the 17‐membered framework of this target by ring‐closing alkyne metathesis (RCAM). This key transformation was accomplished with the aid of the molybdenum alkylidyne complex 7 , which turned out to be compatible with the acid sensitive propargylic alcohol substituents as well as the terminal alkyne unit present in the cyclization precursor. As the presence of such functionality had been detrimental for alkyne metathesis until very recently, this example illustrates the excellent application profile of this new catalyst as well as the rapidly increasing scope of the transformation. Its structural outreach can be further increased by subjecting cyclo‐1,3‐diynes to appropriate post‐metathetic transformations, most notably with the help of alkynophilic gold or palladium catalysts. This aspect is illustrated by the conversion of the model compound 4 into various cyclophane products.     

黄酮糖苷Parkinsonin B的全合成

天然黄酮碳糖苷化合物特有的稳定性和显著的生物活性, 使其化学合成成为当今糖化学领域的研究热点之一. 本工作立体专一性地全合成了天然黄酮碳苷Parkinsonin B. 通过控制物质的量比, 首先高选择性合成了2-羟基-4,6-二甲氧基苯乙酮(3), 并与糖给体O-(2,3,4,6-四-O-苄基-α-D-葡萄糖基)三氯乙酰亚胺酯(7)发生立体专一性糖基化反应得到碳糖苷化合物8, 化合物8经查耳酮路线进而合成黄酮碳苷Parkinsonin B (1). 经IR, MS, ¹H NMR及元素分析证实了产物及中间体的结构, 同时讨论了全合成反应的主要影响因素, 并对其¹H NMR解析进行了探讨.     

Novel Total Synthesis of Mansouramycin B

A novel total synthesis of Mansouramycin B ( 1 ) was performed via 10 steps in 28% overall yield starting from the readily available and cheap salicylaldehyde. Two key steps of this total synthesis are noteworthy. The first one is base‐promoted one‐pot aerobic aromatization of N‐tosyltetrahydroisoquinoline 6 , the second one is oxidation of 5‐hydroxy‐3‐methyl‐isoquinoline 8 with iodobenzene diacetate [PhI(OAc)₂].